Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pediatr Infect Dis J. 2015 May;34(5):463–468. doi: 10.1097/INF.0000000000000608

Figure 4.

Figure 4

Of the 70 emm types observed in Malian school children with pharyngitis, 19 types (VT) were among those covered by the 30-valent vaccine under development. Based on in vitro data, the 30-valent vaccine could induce cross-coverage of an additional 30 non-vaccine types (NVT-K). Six types (NVT-NK) would not be covered; there is no data on the coverage of the remaining 15 types observed.